Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

INTRODUCTION: Ki-67 labeling index assessed by immunohistochemical assays has been shown useful in assessing the risk of recurrence for estrogen receptor (ER)-positive HER2-negative breast cancers (BC) and distinguishing Luminal A-like from Luminal B-like tumors. We aimed to assess the performance o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Viale, Giuseppe, Hanlon Newell, Amy E., Walker, Espen, Harlow, Greg, Bai, Isaac, Russo, Leila, Dell’Orto, Patrizia, Maisonneuve, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2019
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797656/
https://ncbi.nlm.nih.gov/pubmed/31422497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05402-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados